As of May 22
| +0.14 / +1.94%|
The 3 analysts offering 12-month price forecasts for Juniper Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +90.74% increase from the last price of 7.34.
The current consensus among 3 polled investment analysts is to Buy stock in Juniper Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.